Medicine Deal or no deal admin March 16, 2024 1 min read Approaches to M&As in pharma points to each company’s philosophy Continue Reading Previous: NHS to roll out AI to improve waiting times and reduce missed appointmentsNext: Swedish researchers develop new AI computer model to detect lymphatic cancer Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related Stories Bluejay begins phase 3 trial of brelovitug for hepatitis D 2 min read Medicine Bluejay begins phase 3 trial of brelovitug for hepatitis D September 10, 2025 Quotient Sciences and CPI launch RNA drug development venture 2 min read Medicine Quotient Sciences and CPI launch RNA drug development venture September 9, 2025 Eisai unveils promising phase 1b data for narcolepsy drug E2086 1 min read Medicine Eisai unveils promising phase 1b data for narcolepsy drug E2086 September 9, 2025
